Glial alterations in the hippocampus of rats submitted to ibotenic-induced lesion of the nucleus basalis magnocellularis

Behavioural Brain Research

Volumn 190, Issue 2, 2008, Pages 206-211

  Swarowsky, Alessandra ^a   Rodrigues, Letícia ^a   Biasibetti, Regina ^a   Leite, Marina C ^a   de Oliveira, Lucas Fürstenau ^a   de Almeida, Lucia M V ^a   Gottfried, Carmem ^a   Quillfeldt, Jorge A ^a   Achaval, Matilde ^a   Gonçalves, Carlos Alberto ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

GFAP; Glutamate uptake; Hippocampus; Ibotenic acid; Nbm lesion; S100B

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; IBOTENIC ACID; PROTEIN S100B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; AVOIDANCE BEHAVIOR; BRAIN DAMAGE; CEREBROSPINAL FLUID LEVEL; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; ENZYME ACTIVITY; GLIA; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MAGNOCELLULAR NUCLEUS; MALE; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; PROTEIN CONTENT; RAT;

ANIMALS; ASTROCYTES; AVOIDANCE LEARNING; BASAL NUCLEUS OF MEYNERT; BRAIN DAMAGE, CHRONIC; CELL COUNT; CHOLINERGIC FIBERS; DEMENTIA; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FOLLOW-UP STUDIES; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; HABITUATION, PSYCHOPHYSIOLOGIC; HIPPOCAMPUS; IBOTENIC ACID; IMMUNOHISTOCHEMISTRY; MALE; NERVE GROWTH FACTORS; RATS; RATS, WISTAR; S100 PROTEINS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 42249088088     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.02.039     Document Type: Article

References (40)

1. Ahmed M.M., Hoshino H., Chikuma T., Yamada M., and Kato T. Effect of memantine on the levels of glia cells, neuropeptides, and peptide-degrading enzymes in rat brain regions of ibotenic acid-treated Alzheimer's disease model. Neuroscience 126 (2004) 639-649
2. Amenta F., Bronzetti E., Caporali M.G., Ciriaco E., Germana' G.P., Niglio T., et al. Nucleus basalis magnocellularis lesions impair mossy fiber system in rat hippocampus: a quantitative histochemical and ultrastructural study. Arch Gerontol Geriatr 12 (1991) 49-58
3. 2+ elevations in astrocytes in hippocampal slices. J Neurosci 22 (2002) 2443-2450
4. Bennett M.C. The role of alpha-synuclein in neurodegenerative diseases. Pharmacol Ther 105 (2005) 311-331
5. Coleman E., Judd R., Hoe L., Dennis J., and Posner P. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 48 (2004) 166-178
6. Dabir D.V., Robinson M.B., Swanson E., Zhang B., Trojanowski J.Q., Lee V.M.-Y., et al. Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J Neurosci 26 (2006) 644-654
7. Dennis J.C., Coleman E.S., Swyers S.E., Moody S.W., Wright J.C., Judd R., et al. Changes in mitotic rate and GFAP expression in the primary olfactory axis of streptozotocin-induced diabetic rats. J Neurocytol 34 (2005) 3-10
8. de Oliveira L.F., Camboim C., Diehl F., Consiglio A.R., and Quillfeldt J.A. Glucocorticoid-mediated effects of systemic oxytocin upon memory retrieval. Neurobiol Learn Mem 87 (2007) 67-71
9. Diehl F., Fürstenau de Oliveira L., Sánchez G., Camboim C., de Oliveira Alvares L., Lanziotti V.B., et al. Facilitatory effect of the intra-hippocampal pre-test administration of MT3 in the inhibitory avoidance task. Behav Brain Res 177 (2007) 227-231
10. Edvinsson L., Hakanson R., Wahlestedt C., and Uddman R. Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol Sci 8 (1987) 231-235
11. Feoli A.M., Leite M.C., Tramontina A.C., Tramontina F., Posser T., Rodrigues L., et al. Developmental changes in content of glial marker proteins in rats exposed to protein malnutrition. Brain Res 1187 (2008) 33-41
12. Feoli A.M., Siqueira I., Almeida L.M., Tramontina A.C., Battu C., Wofchuk S.T., et al. Brain glutathione content and glutamate uptake are reduced in rats exposed to pre- and postnatal protein malnutrition. J Nutr 136 (2006) 2357-2361
13. Finkelstein Y., Milatovic D., and Aschner M. Modulation of cholinergic systems by manganese. Neurotoxicology 28 (2007) 1003-1014
14. Frank C., Sagratella S., Niglio T., Caporalli M.G., Bronzetti E., and Scotti de Carolis A. Hippocampal long-term potentiation in nucleus basalis magnocellularis-lesioned rats. Brain Res Bull 29 (1992) 847-851
15. Krügel U., Bigl V., Eschrich K., and Bigl M. Deafferentation of the septo-hippocampal pathway in rats as a model of the metabolic events in Alzheimer's disease. Int J Dev Neurosci 19 (2001) 263-277
16. Leite M.C., Brolese G., de Almeida L.M., Piñero C.C., Gottfried C., and Gonçalves C.A. Ammonia-induced alteration in S100B secretion in astrocytes is not reverted by creatine addition. Brain Res Bull 70 (2006) 179-185
17. Maragakis N.J., and Rothstein J.D. Glutamate transporters: animal models to neurologic disease. Neurobiol Dis 15 (2004) 461-473
18. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., and Terry R. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 174 (1994) 67-72
19. Monzón-Mayor M., Álvarez M.I., Arbelo-Galván J.F., Romero-Alemán M.M., Yanes C., Plaza M.L., et al. Long-term evolution of local, proximal and remote astrocyte responses after diverse nucleus basalis lesioning (an experimental Alzheimer model): GFAP immunocytochemical study. Brain Res 865 (2000) 245-258
20. Nagele R.G., Wegiel J., Venkataraman V., Imaki H., Wang K.C., and Wegiel J. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 25 (2004) 663-674
21. Nardin P., Tramontina F., Leite M.C., Tramontina A.C., Quincozes-Santos A., de Almeida L.M., et al. S100B content and secretion decrease in astrocytes cultured in high-glucose medium. Neurochem Int 50 (2007) 774-782
22. Nieto-Escamez F.A., Sanchez-Santed F., and de Bruin J.P. Pretraining or previous non-spatial experience improves spatial learning in the Morris water maze of nucleus basalis lesioned rats. Behav Brain Res 148 (2004) 55-71
23. Oliveira A., Hodges H., and Rezaie P. Excitotoxic lesioning of the rat basal forebrain with S-AMPA: consequent mineralization and associated glial response. Exp Neurol 179 (2003) 127-138
24. Paxinos G. The rat nervous system. 3rd ed. (1997), Academic Press, San Diego
25. Persson A.I., Thorlin T., Bull C., Zarnegar P., Ekman R., Terenius L., et al. Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. Eur J Neurosci 17 (2003) 1159-1172
26. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83 (1977) 346-356
27. Popovic M., Caballero-Bleda M., Popovic N., Puelles L., Van Groen T., and Witter M.P. Vaerapranil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of rat nucleus basalis magnocellularis. Exp Brain Res 170 (2006) 368-375
28. Ritchie K., and Lovestone S. The dementias. Lancet 360 (2002) 1759-1766
29. Robinson S.R. Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease. J Neurosci Res 66 (2001) 972-980
30. Roozendaal B., and McGaugh J.L. Basolateral amygdala lesions block the memory enhancing effect of glucocorticoid administration in the dorsal hippocampus of rats. Eur J Neurosci 9 (1997) 76-83
31. Sharma G., and Vijayaraghavan S. Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci U S A 98 (2001) 4148-4153
32. 2+-elevating muscarinic cholinergic and histaminergic receptors in situ. J Neurochem 74 (2000) 555-563
33. Shoham S., Bejar C., Kovalev E., and Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 184 (2003) 1043-1052
34. Teaktong T., Graham A.J., Court J.A., Perry R.H., Jaros E., Johnson M., et al. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology. J Neurol Sci 225 (2004) 39-49
35. Toledano A., and Alvarez M.I. Lesion and dysfunctions of the nucleus basalis as Alzheimer's disease models: general and critical overview and analysis of long term changes in several excitotoxic models. Curr Alzheimer Res 1 (2004) 189-214
36. Vale-Martinez A., Baxter M.G., and Eichenbaum H. Selective lesions of basal forebrain cholinergic neurons produce anterograde and retrograde deficits in a social transmission of food preference task in rats. Eur J Neurosci 16 (2002) 983-998
37. Van Eldik L., and Wainwright M.S. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 21 (2003) 97-108
38. Volterra A., and Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continue. Nature 6 (2005) 625-640
39. Weinstock M., and Shoham S.J. Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity. Neural Transm 111 (2004) 347-366
40. Yamamoto M., Chikuma T., and Kato T. Changes in the levels of neuropeptides and their metabolizing enzymes in the brain regions of nucleus basalis magnocellularis-lesioned rats. J Pharmacol Sci 92 (2003) 400-410